Group One Trading
SCMP

Group One Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Group One Trading’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-48,700
Closed -$874K – 5698
2017
Q4 		$874K Buy
48,700
+48,600
+48,600% +$598K 0.01% 1824
2017
Q3 		$1K Hold
100
– – ﹤0.01% 4746
2017
Q2 		$1K Sell
100
-17,900
-99% -$182K ﹤0.01% 4678
2017
Q1 		$198K Sell
18,000
-1,400
-7% -$16.2K ﹤0.01% 2531
2016
Q4 		$263K Buy
+19,400
New +$271K ﹤0.01% 2238
2016
Q2 		– Sell
-400
Closed -$4K – 5177
2016
Q1 		$4K Sell
400
-3,700
-90% -$46.8K ﹤0.01% 4276
2015
Q4 		$71K Buy
4,100
+3,200
+356% +$57.4K ﹤0.01% 3213
2015
Q3 		$18K Buy
900
+800
+800% +$18.3K ﹤0.01% 4093
2015
Q2 		$2K Sell
100
-1,900
-95% -$32.9K ﹤0.01% 4713
2015
Q1 		$31K Buy
+2,000
New +$31K ﹤0.01% 3667
2014
Q3 		– Sell
-1,000
Closed -$7K – 5663
2014
Q2 		$7K Hold
1,000
– – ﹤0.01% 4668
2014
Q1 		$7K Buy
+1,000
New +$8.56K ﹤0.01% 4734
2013
Q4 		– Sell
-8,800
Closed -$55K – 5724
2013
Q3 		$55K Buy
8,800
+8,200
+1,367% +$51.2K ﹤0.01% 3476
2013
Q2 		$4K Buy
+600
New +$4.76K ﹤0.01% 4780

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Group One Trading's SCMP Position: Q1 2018 in Review

Group One Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 27,735 shares — an estimated $498K sold.

Group One Trading first reported a position in SCMP in Q3 2013 and held it in 6 quarters. The position peaked at $498K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Group One Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Group One Trading sold 27,735 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $498K.
  • Group One Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
  • Group One Trading's Sucampo Pharmaceuticals, Inc. position peaked at $498K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.